Foresite Capital Management IV’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-94,666
Closed -$1.48M 16
2017
Q4
$1.48M Buy
+94,666
New +$1.48M 1.04% 12